HRP20041022B1 - Injektibilni veterinarski pripravci za male “ivotinje - Google Patents

Injektibilni veterinarski pripravci za male “ivotinje

Info

Publication number
HRP20041022B1
HRP20041022B1 HRP20041022AA HRP20041022A HRP20041022B1 HR P20041022 B1 HRP20041022 B1 HR P20041022B1 HR P20041022A A HRP20041022A A HR P20041022AA HR P20041022 A HRP20041022 A HR P20041022A HR P20041022 B1 HRP20041022 B1 HR P20041022B1
Authority
HR
Croatia
Prior art keywords
small animals
veterinary composition
injectable veterinary
carprofen
injectable
Prior art date
Application number
HRP20041022AA
Other languages
English (en)
Inventor
Blakely William
Cromie Lillian
Duffy Sean
Original Assignee
Norbrook Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Laboratories Limited filed Critical Norbrook Laboratories Limited
Publication of HRP20041022A2 publication Critical patent/HRP20041022A2/xx
Publication of HRP20041022B1 publication Critical patent/HRP20041022B1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Otopina za injektiranje stabilna na sobnoj temperaturi za veterinarsku uporabu, naznačena time da se sastoji od 0,25 do 30% (masa/volumen) karprofena (6-kloro- -metil-karbazol-2-octena kiselina) ili fiziolo®ki prihvatljive soli karprofena, i od 0,5% do 20% (masa/volumen) poloksamera, te vode q.s. za injektiranje. Patent sadr·i jo® 13 patentnih zahtjeva.
HRP20041022AA 2002-04-02 2004-10-29 Injektibilni veterinarski pripravci za male “ivotinje HRP20041022B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0207529.9A GB0207529D0 (en) 2002-04-02 2002-04-02 Injectable veterinary composition for small animals
PCT/GB2003/001404 WO2003082340A1 (en) 2002-04-02 2003-03-31 Injectable veterinary composition for small animals

Publications (2)

Publication Number Publication Date
HRP20041022A2 HRP20041022A2 (en) 2005-02-28
HRP20041022B1 true HRP20041022B1 (hr) 2012-09-30

Family

ID=9934049

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20041022AA HRP20041022B1 (hr) 2002-04-02 2004-10-29 Injektibilni veterinarski pripravci za male “ivotinje

Country Status (21)

Country Link
US (1) US7879899B2 (hr)
EP (1) EP1494719B1 (hr)
JP (2) JP4689164B2 (hr)
KR (1) KR100884680B1 (hr)
CN (1) CN1265838C (hr)
AU (1) AU2003215771B2 (hr)
BR (1) BR0308874B1 (hr)
CA (1) CA2480065C (hr)
CR (1) CR7515A (hr)
DK (1) DK1494719T5 (hr)
ES (1) ES2659940T3 (hr)
GB (2) GB0207529D0 (hr)
HK (1) HK1077004A1 (hr)
HR (1) HRP20041022B1 (hr)
IL (2) IL164303A0 (hr)
MX (1) MXPA04009407A (hr)
NO (1) NO334122B1 (hr)
NZ (1) NZ535442A (hr)
PL (1) PL218606B1 (hr)
WO (1) WO2003082340A1 (hr)
ZA (1) ZA200408405B (hr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1758590T1 (sl) * 2004-05-19 2012-03-30 Los Angeles Biomed Res Inst Uporaba detergenta za nekirurško odstranitev maščobe
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
IL195602A (en) * 2008-11-30 2016-09-29 Orna Levin The arginine-based composition for oral administration
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
EP2675460A4 (en) 2011-02-18 2014-07-09 Kythera Biopharmaceuticals Inc TREATMENT OF FAT TISSUE UNDER CHIN
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
CN102793700B (zh) * 2012-08-29 2014-03-12 郑州后羿制药有限公司 一种含氟甲喹的复方油乳注射液及其制备方法
CN104146951B (zh) * 2014-07-02 2017-01-11 沈阳双鼎制药有限公司 一种右旋布洛芬注射液及其制备方法
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
CN107198676B (zh) * 2017-06-23 2022-04-01 燃点(南京)生物医药科技有限公司 一种供静脉给药用的布洛芬注射液
CN110169951A (zh) * 2019-05-17 2019-08-27 河北远征药业有限公司 一种兽用卡洛芬注射液及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH663788A5 (en) * 1985-02-22 1988-01-15 Hoffmann La Roche New amino acid salts of carprofen - useful as antiinflammatory agents and analgesics
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
EP0955063A1 (de) * 1998-04-01 1999-11-10 Basf Aktiengesellschaft Verwendung von wässrigen Zusammensetzungen in subkutanen oder intramuskulär zu verabreichenden Arzneimittel

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH673395A5 (hr) * 1987-01-30 1990-03-15 Ciba Geigy Ag
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
US5434170A (en) * 1993-12-23 1995-07-18 Andrulis Pharmaceuticals Corp. Method for treating neurocognitive disorders
SE502225C2 (sv) * 1994-01-12 1995-09-18 Whirlpool Europ Mikrovågsugn
JPH07223942A (ja) * 1994-02-03 1995-08-22 Ildong Pharm Co Ltd プロピオン酸系非ステロイド性薬物を有効成分として含有する新規消炎鎮痛外用ゲル製剤
CN1106259A (zh) * 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
IT1277430B1 (it) 1995-08-03 1997-11-10 Bayer Italia Spa Preparazioni farmaceutiche per uso topico a base di ketoprofene
US20010049363A1 (en) 1998-05-08 2001-12-06 Warner-Lambert Company Oral composition containing NSAIDs and essential oils
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
SE0100901D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab New composition
ES2189682B1 (es) 2001-12-11 2004-04-01 Laboratorios Del Dr. Esteve, S.A. Preparacion bebible que comprende ketoprofeno y su empleo en el tratamiento de procesos que cursan con fiebre, inflamacion y/o dolor, en un colectivo de animales, de forma simultanea.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH663788A5 (en) * 1985-02-22 1988-01-15 Hoffmann La Roche New amino acid salts of carprofen - useful as antiinflammatory agents and analgesics
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
EP0955063A1 (de) * 1998-04-01 1999-11-10 Basf Aktiengesellschaft Verwendung von wässrigen Zusammensetzungen in subkutanen oder intramuskulär zu verabreichenden Arzneimittel

Also Published As

Publication number Publication date
CA2480065C (en) 2010-09-28
HRP20041022A2 (en) 2005-02-28
AU2003215771B2 (en) 2008-08-14
CN1646169A (zh) 2005-07-27
CN1265838C (zh) 2006-07-26
PL218606B1 (pl) 2015-01-30
GB0307484D0 (en) 2003-05-07
JP2005527561A (ja) 2005-09-15
NZ535442A (en) 2007-05-31
DK1494719T5 (en) 2018-03-12
HK1077004A1 (en) 2006-02-03
KR20050002920A (ko) 2005-01-10
BR0308874A (pt) 2005-01-04
JP2010195823A (ja) 2010-09-09
ZA200408405B (en) 2005-09-28
EP1494719A1 (en) 2005-01-12
JP4689164B2 (ja) 2011-05-25
DK1494719T3 (en) 2018-03-05
AU2003215771A1 (en) 2003-10-13
IL164303A0 (en) 2005-12-18
BR0308874B1 (pt) 2014-06-10
NO334122B1 (no) 2013-12-16
KR100884680B1 (ko) 2009-02-18
CR7515A (es) 2008-07-29
US20050147680A1 (en) 2005-07-07
WO2003082340B1 (en) 2003-12-24
GB2387327A (en) 2003-10-15
MXPA04009407A (es) 2005-01-25
EP1494719B1 (en) 2018-02-14
IL164303A (en) 2008-08-07
US7879899B2 (en) 2011-02-01
NO20044723L (no) 2004-11-01
GB2387327B (en) 2005-01-26
CA2480065A1 (en) 2003-10-09
ES2659940T3 (es) 2018-03-20
GB0207529D0 (en) 2002-05-08
WO2003082340A1 (en) 2003-10-09
PL372706A1 (en) 2005-07-25

Similar Documents

Publication Publication Date Title
HRP20041022B1 (hr) Injektibilni veterinarski pripravci za male “ivotinje
CY1123084T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι
ATE362314T1 (de) Herbizidzusammensetzungen umfassend imidazolinonsäure
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
ME00864B (me) Farmaceutski sastav koji sadrži inhibitore protonske pumpe
ATE548020T1 (de) Kombinationen für orale zusammensetzungen, ihre herstellung und verwendung
RS53312B (en) TERNARY HERBICIDE COMPOSITIONS CONTAINING AMINOPYRALID AND IMAZAMOX
DK2219665T3 (da) Parathyroidhormonformuleringer og anvendelse deraf
DK1460893T3 (da) Strøelse til dyr
ATE392889T1 (de) Orale antimikrobielle pharmazeutische zusammensetzungen
DE60236971D1 (de) Stabilisierung von wässerigen zusammensetzungen von 18f-markiertem 2-fluoro-2-deoxy-d-glukose mit ethanol
AR024380A1 (es) Tienopirimidinas
BR0102134A (pt) Composição para ração para um animal de criação, ração, e, método para aumentar a eficiência de ganho de peso corpóreo e a eficiência de ração do animal de criação
ATE430571T1 (de) Wässrige pharmazeutische formulierungen von wasserlöslichen prodrugs von propofol- verbindungen
FR2848851B1 (fr) Procede d'obtention d'un principe actif presentant des capacites apaisantes, principe actif et compositions obtenues
HRP20020181B1 (hr) Farmaceutski pripravci koji sadrže derivat benzamida kao aktivan sastojak
ATE298256T1 (de) Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung
CY1105105T1 (el) Χρηση του διστροντιου αλατος του 2-[ν,ν-δι(καρβοξυμεξυλ) amino]- 3-κυανο-4-καρβοξυμεθυλ-θειοφενο-5-καρβοξυλικου οξεος για τη ληψη φαρμακων που προοριζονται για τη θεραπεια γαστρο-δωδεκαδακτυλικων πονων
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
ATE327980T1 (de) 3-heterocyclyl-substituierte benzoesäurederivate
PT971880E (pt) Composicoes solidas adequadas para administracao oral compreendendo sais nao-hidroscopicos de l-carnitina e alcanoil-l-carnitina com acido 2-aminoetanossulfonico
TR200401815T4 (tr) Evcil hayvanlarda pirimidin endotelin antagonistlerinin kullanımı.
PE20070787A1 (es) Composicion acuosa de una solucion amoniacal de azida de sodio
AR042528A1 (es) Procedimiento para preparar una composicion acuosa blanqueadora de perborato
DE602006009511D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Hauterkrankungen

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20170307

Year of fee payment: 15

PBON Lapse due to non-payment of renewal fee

Effective date: 20180331